Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden
· Delayed Price · Currency is SEK 466.20
-3.80 (-0.81%)
Jun 26, 2026, 5:29 PM CET
Swedish Orphan Biovitrum AB Employees
Swedish Orphan Biovitrum AB had 1,862 employees as of December 31, 2025. The number of employees increased by 56 or 3.10% compared to the previous year.
Employees
1,862
Change (1Y)
56
Growth (1Y)
3.10%
Revenue / Employee
14.71M SEK
Profits / Employee
467.75K SEK
Market Cap
161.23B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioGaia AB | 243 |
| Cereno Scientific AB | 10 |
| Orexo AB | 65 |
| EQL Pharma AB | 60 |
| Nanexa AB | 16 |
| Enzymatica AB | 21 |
| Cinclus Pharma Holding AB | 17 |
| Moberg Pharma AB | 5 |
Swedish Orphan Biovitrum AB News
- 1 day ago - FDA declines to approve Sobi's gout therapy on concerns over manufacturing - Reuters
- 7 weeks ago - Swedish Orphan Biovitrum initiated with a Buy at H.C. Wainwright - TheFly
- 2 months ago - Swedish Orphan Biovitrum AB Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Swedish Orphan Biovitrum AB Quarterly report: Q1 2026 - Filings
- 2 months ago - Swedish Orphan Biovitrum AB Slides: Q1 2026 - Filings
- 3 months ago - Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 4 months ago - Swedish Orphan Biovitrum AB Slides: Investor presentation - Filings
- 4 months ago - Swedish Orphan Biovitrum price target raised to SEK 470 from SEK 395 at Barclays - TheFly